Provider review
T2D.com review
Says the medication is inside the service repeatedly, and never says what the service costs.
The fee structure is published and the number is not, and the only path onward collects your contact details first.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
T2D.com
No price published; contact details required first
- Vs median
- Not comparable — no figure is published before intake
- Market
- $59–$1300/mo across 242 of 373
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
T2D.com is unusually clear about one thing and silent about the other. The clear part is the fee structure: it says in several separate places that the medication is included in the service and is not a separate purchase, which rules out the stacked billing that trips up so much of this category, where a low headline turns out to be the consultation and the drug is charged beside it. That is a real statement and a useful one. The silent part is everything a price is made of. There is no figure on the site — not a floor, not a range, not a plan tier — and the only way forward is a form that takes a name, an email address and a phone number before it shows anything. So the structure is published and the number is not, which is an odd way round: a reader learns that whatever they are quoted will be the whole bill without learning what it is. Both molecules are named and both are stated to be compounded, which is more than several providers here manage even when they do publish a price. For a reader whose question is what a deliberately small dose costs, none of that is reachable. No milligram appears, no plan length appears, and nothing says whether the service bills monthly or by supply. The framing is worth noting too: this is presented as diabetes and pre-diabetes care first, with weight loss as a route off it rather than the main subject.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You are managing type 2 diabetes or pre-diabetes and want that to be the primary framing
- You want the prescriber and the medication arranged as one service rather than separately
- You want a plain statement that the drug is not billed on top of the program
Look elsewhere if
- You want to know the cost before giving out your name, email address and phone number
- You are costing a small dose. No milligram, plan length or billing cadence is published
- You want to compare two molecules on price. Both are named and neither is priced
What it actually costs
Price as published
No figure is published anywhere on the public site. The offering is described as a "complete service" that includes the prescriber, the medication and home delivery, with compounded semaglutide and compounded tirzepatide named as the available medications · the page states repeatedly that the medication is part of the service rather than a separate purchase, which describes the fee structure without pricing it · the only path onward is a form collecting first name, last name, email and phone before anything further is shown, so no rung is reachable without handing over contact details · no dose, no plan length and no billing cadence are published · the site is framed around type 2 diabetes and pre-diabetes care rather than weight loss, with the weight-loss route reached through a separate page
- Vs median
- Not comparable — no figure is published before intake
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- No low-dose price published
A low-dose lane may exist, but nothing public says what it costs — so the one question this page exists to answer cannot be answered before you sign up.
52 of the 373 programs we track price a small dose this way. No figure is published anywhere on the public site — not a floor, not a range, not a plan tier — and the only path onward collects a name, email address and phone number before showing anything. The fee STRUCTURE is stated clearly and repeatedly, that the medication is included in the service rather than bought separately, which rules out the stacked billing common in this category; the number that structure applies to is the part missing. Both molecules are named and both are stated to be compounded. No dose, plan length or billing cadence appears, so a low dose cannot be costed in advance even in principle.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- States plainly and repeatedly that the medication is inside the service, not billed beside it.
- Names both molecules and states both are compounded, rather than implying branded products.
- The prescriber is stated to be part of the service, so no separate consultation is arranged.
Pharmacy, labs and oversight
T2D.com does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What T2D.com publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
T2D.com is unusually clear about one thing and silent about the other. The clear part is the fee structure: it says in four separate places that the medication is included in the service and is not a separate purchase, which rules out the stacked billing that trips up so much of this category, where a low headline turns out to be the consultation and the drug is charged beside it. That is a real statement and a useful one. The silent part is everything a price is made of. There is no figure on the site — not a floor, not a range, not a plan tier — and the only way forward is a form that takes a name, an email address and a phone number before it shows anything. So the structure is published and the number is not, which is an odd way round: a reader learns that whatever they are quoted will be the whole bill without learning what it is. Both molecules are named, which is more than several providers here manage even when they do publish a price, and both are stated to be compounded. For a reader whose question is what a deliberately small dose costs, none of that is reachable. No milligram figure appears, no plan length appears, and nothing says whether the service bills monthly or by supply. The framing is also worth noting: this is presented as diabetes and pre-diabetes care first, with weight loss as a route off it rather than the main subject.
The honest cons
No figure is published anywhere — not a floor, not a range, not a plan tier.
- The only path forward collects a name, email and phone number before showing anything.
- No dose, plan length or billing cadence appears, so nothing can be costed in advance.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
T2D.com is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#229 of 373
Ordered with the companies that pay us first, and T2D.com is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Care Bare Rx
From $199/mo*
- Vs median
- $30/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Care Bare Rx review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.